Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, researches, develops, manufactures, and sells therapeutic drugs, health care foods, and medical beauty products in Taiwan and internationally. It produces anti-cancer pharmaceuticals, such as injections, solid reagents, and hormone reagents; and tablets, soft gel capsules and powder and canned special nutrient products. The company also offers shampoo, body wash, tonic water, lotions, moisturizers, sunscreen lotions, and serums; and pharmaceutical packaging products, such as eye drop bottles, dry canisters, tablet bottles, and various medical grade plastic containers. In addition, it provides plant extracts and functional foods; and OEM services, such as product design, manufacturing, etc. to manufacturers. The company was founded in 1977 and is headquartered in Yilan City, Taiwan.
Sinphar Pharmaceutical Dividend Announcement
• Sinphar Pharmaceutical announced a annually dividend of NT$1.00 per ordinary share which will be made payable on 2024-10-08. Ex dividend date: 2024-09-04
• Sinphar Pharmaceutical annual dividend for 2024 was NT$1.00
• Sinphar Pharmaceutical annual dividend for 2023 was NT$1.00
• Sinphar Pharmaceutical's trailing twelve-month (TTM) dividend yield is 3.03%
• Sinphar Pharmaceutical's dividend growth over the last five years (2018-2023) was 37.97% year
• Sinphar Pharmaceutical's dividend growth over the last ten years (2013-2023) was 6.47% year
Sinphar Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-09-04 | NT$1.00 | annually | 2024-10-08 |
2023-07-13 | NT$1.00 | annually | 2023-08-18 |
2022-07-21 | NT$0.20 | annually | 2022-08-25 |
2021-08-31 | NT$0.20 | annually | 2021-09-24 |
2020-07-23 | NT$0.20 | annually | 2020-08-26 |
2019-07-17 | NT$0.10 | annually | 2019-08-16 |
2018-07-23 | NT$0.20 | annually | 2018-08-24 |
2017-07-11 | NT$0.10 | annually | 2017-08-14 |
2016-09-01 | NT$0.20 | annually | |
2015-07-30 | NT$0.77 | annually | |
2014-07-03 | NT$0.71 | annually | |
2013-07-09 | NT$0.53 | annually |
Sinphar Pharmaceutical Dividend per year
Sinphar Pharmaceutical Dividend growth
Sinphar Pharmaceutical Dividend Yield
Sinphar Pharmaceutical current trailing twelve-month (TTM) dividend yield is 3.03%. Interested in purchasing Sinphar Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
Sinphar Pharmaceutical Financial Ratios
Sinphar Pharmaceutical Dividend FAQ
Other factors to consider when evaluating Sinphar Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Sinphar Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Sinphar Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Sinphar Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Sinphar Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Sinphar Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Sinphar Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Sinphar Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Sinphar Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Sinphar Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Sinphar Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.